Published online before print July 14, 2003, doi: 10.1161/01.CIR.0000080915.35024.A9
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2003;108:432.)
© 2003 American Heart Association, Inc.
Clinical Investigation and Reports |
Magnetic Resonance Perfusion Measurements for the Noninvasive Detection of Coronary Artery Disease
From Cardiology, German Heart Institute (E.N., C.K., I.P., S.H., E.F.), Berlin, Germany; Philips Research Laboratories (B.S.), Hamburg, Germany; and University of Hamburg, Institute for Statistics and Econometry (K.W.), Hamburg, Germany.
Correspondence to Eike Nagel, MD, Cardiology, German Heart Institute, Augustenburger Platz 1, 13353 Berlin, Germany. E-mail eike.nagel{at}dhzb.de
Received September 24, 2002; de novo received February 6, 2003; revision received April 29, 2003; accepted May 2, 2003.
 |
Abstract |
|---|
 Top Abstract IntroductionMethodsResultsDiscussionReferences |
|---|
Background— With MRI, an index of myocardial perfusion reserve (MPRI) can be determined. We assessed the value of this technique for the noninvasive detection of coronary artery disease (CAD) in patients with suspected CAD.
Methods and Results— Eighty-four patients referred for a primary diagnostic coronary angiography were examined with a 1.5 T MRI tomograph (Philips-ACS). For each heartbeat, 5 slices were acquired during the first pass of 0.025 mmol gadolinium-diethylenetriamine pentaacetic acid/kg body weight before and during adenosine vasodilation by using a turbo-gradient echo/echo-planar imaging-hybrid sequence. MPRI was determined from the alteration of the upslope of the myocardial signal intensity curves for 6 equiangular segments per slice. Receiver operating characteristics were performed for different criteria to differentiate ischemic and nonischemic segments. Prevalence of CAD was 51%. Best results were achieved when only the 3 inner slices were assessed and a threshold value of 1.1 was used for the second smallest value as a marker for significant CAD. This approach yielded a sensitivity of 88%, specificity of 90%, and accuracy of 89%.
Conclusion— The determination of MPRI with MRI yields a high diagnostic accuracy in patients with suspected CAD.
Key Words: magnetic resonance imaging • perfusion • coronary disease
|
Introduction |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
Alterations of myocardial perfusion are highly sensitive for the detection of myocardial ischemia. In clinical practice, perfusion is usually assessed with single-photon emission tomography (SPECT) or PET, which reaches sensitivities and specificities from 83% to 95% and 53% to 95%.1–4 SPECT is limited by the occurrence of attenuation artifacts, which can be found mainly in obese patients and women.4 In addition, the application of radioactive tracers prohibits follow-up examinations. Although myocardial perfusion can be quantitatively assessed with PET, the technique is limited by its reduced availability.
Myocardial perfusion can be assessed with cardiovascular MRI at rest and during pharmacological vasodilation, and results from animal experiments have shown a correlation (r2=0.87) with microspheres for the assessment of blood flow.5 Flow differences of a factor 
2 can be detected,5 which occur in patients with 70% coronary artery stenosis during vasodilation. Preliminary studies with small patient populations have shown promising results.6–12 Parameters for the assessment of myocardial perfusion are usually gained by analyzing the first pass of a contrast agent bolus through the myocardium.6,9,13,14 With extensive modeling, quantitative determination of myocardial perfusion is possible; however, this approach relies on several assumptions that may not be fulfilled in patients.13,15–17 We have recently shown that a linear fit of the upslope is easy to perform, is highly reproducible, and shows promising accuracy in a selected patient population.18 Visual assessment may allow for a rapid diagnosis without the need for quantification.
We aimed to optimize the approach for evaluating MR perfusion measurements and to determine their value for the detection of significant stenoses in patients with suspected coronary artery disease (CAD).
|
Methods |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
Patients
All patients gave written informed consent. Ninety consecutive patients (73 male; age, 63±8 years; body weight, 75±11 kg; 21% smokers) with suspected CAD who were scheduled for a primary diagnostic invasive coronary angiography were included, 84 of which form the analysis population (see Results).
Patients with myocardial infarction <7 days, unstable angina pectoris, arterial hypertension (>160/140 mm Hg), diabetes mellitus, ejection fraction <50%, atrial flutter or fibrillation, sick sinus rhythm, SA- or AV-block >I, ventricular premature beats (Lown-III), relevant obstructive pulmonary disease or valvular disease II, or contraindications to the MR examination (incompatible metallic implants, claustrophobia) were excluded. To ensure minimal basal blood flow and a maximal vasodilatory response to adenosine, patients were instructed to refrain from smoking, tea, or coffee, as well as ß-blockers and antianginal medication, for 24 hours before the examination. Patients were excluded from the study if they had not followed these instructions.
Magnetic Resonance Imaging
All patients were examined in the supine position (1.5 T ACS-NT, Philips) using a 5-element phased-array cardiac coil. After determination of the axis and length of the left ventricular (LV) cavity, 5 short-axis planes were imaged. The distance between each plane was individually set as one sixth of the end-systolic length of the LV cavity. A single shot segmented k-space turbo-gradient-echo/echo-planar-imaging (EPI)-hybrid technique (echo time [TE], repetition time [TR], and flip: 3.3, 12.5, and 30, respectively; 4 
-pulses followed by 11 EPI readouts each; spatial resolution, 1.7 to 2.2 mmx1.9 to 2.4 mm; slice thickness, 8 mm; 5 images per heart beat; 1 saturation prepulse for all slices; prepulse delay, 200, 300, 400, 500, and 600 ms for slices 1, 3, 5, 2, and 4, respectively) was used (Figure 1). Images were acquired during breath-holding for 10 heartbeats before and 60 heartbeats during the first pass of 0.025 mmol gadolinium-diethylenetriamine pentaacetic acid (DTPA)/km body weight (Schering) flushed with 10 mL 0.9%NaCl (flow rate, 8 mL/s; Medrad, Spectris).
|
After 15 minutes to allow for the clearance of the first contrast agent injection, 0.14 mg adenosine · kg body weight-1 · min-1 were infused for 4 minutes under continuous ECG and blood pressure monitoring. During the last minute of the infusion, the perfusion scan was repeated.
Coronary Angiography
After the MR examination, all patients underwent biplane coronary angiography in Judkins’ technique. Two experienced blinded observers visually assessed the coronary angiographies. When needed, quantitative assessment was performed by a third blinded observer (ARRI, Munich, Germany). Hemodynamically relevant CAD was defined as 75% area reduction with respect to prestenotic segment area in at least 1 major epicardial coronary artery or major branch (>2.5-mm diameter). Patients were classified as having 1-, 2-, or 3-vessel disease. Coronary artery territories were defined from the angiogram in patients with 1-vessel disease by using the American Heart Association/American College of Cardiology guidelines.19
Image Analysis
The endocardial and epicardial contours were traced by an examiner blinded to angiography (MASS, Medical Imaging Solutions, Leiden, the Netherlands) and corrected manually for displacements (eg, breathing). The inner 10% and outer 30% of the myocardium were excluded to get stronger weighting of the subendocardium and reduce influences from the LV. The myocardium was divided into 6 equiangular segments per slice. LV signal intensity (SI) of the basal slice and myocardial SI were determined for all time points (Figure 2). Mean SI before contrast agent injection was subtracted from all postcontrast data, and the upslope of the resulting SI time curves was determined by using a linear fit of 4 consecutive images in myocardial curves (2 in the LV curves to account for the shorter bolus duration in the LV versus the myocardium). The results of the myocardial segments were corrected for differences of the speed and compactness of the contrast agent bolus by division of the myocardial upslope through the LV upslope. An index for myocardial perfusion reserve (MPRI) was calculated by dividing the results at maximal vasodilation through the results at rest.18
|
) when compared with rest (
, whereas in the inferior segment of the same slice there is no change of the upslope after vasodilation with adenosine.A patient was classified as having significant CAD if the minimum MPRI (one segment) was below the cutoff in any slice or the 3 inner slices only, or the second smallest MPRI (any 2 segments) was below the cutoff in any slice or the 3 inner slices only.
Visual Assessment
Rest and stress images were visually compared. If a segment showed a reduced peak SI or delayed wash-in at stress but not at rest, it was regarded as pathological.
Statistical Analysis
Continuous variables are expressed as mean±1 SD. Group differences were tested by using Student’s t test for continuous variables. Significance was defined as P<0.05. Receiver operating characteristic (ROC) analyses were performed to evaluate the diagnostic potential of each of the indicators used for semiquantitative assessment. Areas under the curve (AUCs) were determined and cutoff values chosen that maximized the Youden-criterion for each indicator. Sensitivities, specificities, and diagnostic accuracies were determined with regard to each cutoff. In patients with 1-vessel disease, location was determined by using the segment with the smallest perfusion index, as well as the segment with the second smallest perfusion index, and compared with invasive angiography.
|
Results |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
Patient Population
In 6 patients (7%), MRI could not be successfully completed. This was owing to claustrophobia (n=3), obesity (>150 kg body weight, n=1), severe anginal symptoms (n=1), or AV block III (n=1). In 5% of patients, examination conditions were difficult owing to strong breathing artifacts during adenosine infusion (n=1), delayed delivery of the contrast agent (n=2), or MRI artifacts (susceptibility artifacts) in the anterior segments (n=1). However, these patients were kept in the final analysis.
Table 1 lists the hemodynamic results. Most patients had minimal side effects (flush, warmth, headache), 6 had angina, and one had AV-block II that resolved within 30 seconds after stopping the infusion.
|
SI Time Curves
Analysis time to extract the relevant parameters was 
30 minutes per patient. The upslopes for different myocardial segments showed a systematic difference both at rest and stress, with higher values of the anterior in comparison to the inferior segments. However, these differences were corrected for by the calculation of the MPRI (Figure 3).
|
) and stress (
) for the different segments (S1 to S6, clockwise) (see Individual patients showed large variations of LV upslopes between rest and stress, with only a mild correlation (upslope at stress=0.65xupslope at rest+40; r=0.59). Correction of the MPRI on the individual LV upslopes led to a smaller variation of data, resulting in a better differentiation between patients with and without significant CAD (Figure 4).
|
Diagnostic Accuracy
Prevalence of hemodynamically relevant CAD was 51% (43 patients). Nineteen patients had 1-vessel disease, 9 patients had 2-vessel disease, and 15 patients had 3-vessel disease.
The comparison of MR perfusion with angiography is shown in Table 2. AUC was largest when only the 3 inner slices were evaluated and the second smallest value was used to determine the cutoff value, which reached a maximum at 1.1 (Figure 5), yielding 88% sensitivity with 90% specificity. In patients with 1-vessel disease, sensitivity was 84%, in 2-vessel disease sensitivity was 90%, and in 3-vessel disease sensitivity was 93%.
|
|
Determination of Disease Location
In 18 of 19 patients (94.7%) with 1-vessel disease, the segment with the lowest MPRI of 5 or 3 slices correctly identified the location of the stenotic coronary artery.
Determination of Disease Severity
The number of diseased vessels correlated with the number of ischemic segments (r=0.71), without a clear cutoff value to determine disease severity owing to overlap between the groups.
Visual Assessment
Visual analysis required 10 minutes per patient. Fifty-six patients were correctly diagnosed for the presence or absence of CAD (sensitivity, 74%; specificity, 58%; accuracy, 65.5%) by using all 5 slices, and 62 patients (sensitivity, 70%; specificity, 78%; accuracy, 74%) were diagnosed by using the 3 inner slices. Sensitivity was 79% for 1-vessel disease, 88% for 2-vessel disease, and 77% for 3-vessel disease.
|
Discussion |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
MR perfusion measurements allow diagnosing hemodynamically relevant CAD with high diagnostic accuracy. A MPRI can be assessed from alterations of the upslope of the first-pass SI curves after injection of a gadolinium-DTPA bolus at rest and during adenosine stimulation. A diagnostic accuracy of 89% was achieved when segments in the 3 inner slices were below the ischemic threshold using a ROC analysis.
Since the first studies reporting the feasibility of MR to determine myocardial perfusion from the first pass of a contrast agent bolus,6,7 MR techniques have developed rapidly and now allow the acquisition of several slices each heartbeat with high spatial resolution. Some investigators have recently examined the value of MR perfusion measurements to detect myocardial ischemia in small or selected patient collectives10,11,18,20–22 and found similar results as reported in the present study. In the present study, no comparison to other techniques assessing myocardial perfusion (SPECT, PET) was performed, but the MR results were compared with those of invasive angiography. Even though this approach has the disadvantage to assess different pathophysiologies (perfusion versus epicardial stenosis), there are also advantages: in clinical routine, the decision whether or not to proceed to revascularization is most frequently based on invasive angiography, and SPECT and PET imaging have inherent drawbacks, potentially yielding false-positive or false-negative results.
In a recent study,12 MR perfusion measurements were compared with those from PET and angiography. Diagnostic accuracy in comparison to angiography was slightly lower than in the present study. This may be owing to a different evaluation strategy, taking only the upslope during vasodilation into account and defining different thresholds for different segments. In addition, images were acquired every second heartbeat only, which might introduce an error owing to temporal undersampling.
In our analysis, the calculation of a perfusion reserve index from the upslopes at rest and stress after correction for the upslope in the LV allowed for the best detection of CAD. This approach was superior to the assessment of the upslope at stress alone or the simple division of the upslope at stress through the upslope at rest. The calculation of a perfusion reserve, rather than using the upslopes at stress, is a way to correct for signal differences within the image. Because a surface coil was used for image acquisition, different signal intensities were gained in the anterior and inferior myocardial regions. This may be corrected for by using different thresholds for different myocardial regions, as suggested by Schwitter et al.12 However, different placement of the surface coil or different patient anatomy may require different thresholds in different patients. Our approach led to similar perfusion reserve indexes for all myocardial regions, independent of the distance from the coil. A similar approach has been recently reported in healthy volunteers and 25 patients with documented CAD, yielding a sensitivity of 69% and specificity of 89% versus values for angiography.23 These numbers are lower than those reported in the present study, probably because no correction for the LV input function was performed.
A potential alternative approach may be a stress scan followed by scar imaging to detect myocardial infarction. Although this approach may improve visual assessment, it does not allow calculation of perfusion reserve and was not performed in the current study.
Evaluating only the 3 inner slices resulted in a higher accuracy for the detection of significant CAD than did the evaluation of all 5 slices, which may be explained by several reasons. The ischemic area induced by most coronary artery stenoses is usually not limited to a small basal or apical area but extends to the equatorial level. The apical slice is visualized during systole, whereas all other slices are visualized more within diastole, and thus, intracapillary blood volume is lower. In addition, the apical slice has more partial volume effects owing to the conical shape of the LV. The basal slice is frequently influenced by the outflow tract and thus has more regional inhomogeneities. These factors led to more overlap between ischemic and nonischemic segments of the outer 2 slices.
The analysis of the second smallest value is a way to reduce the probability of outliers to influence the results. This approach led to an increase of the AUC, indicating that outliers are an important problem for the imaging approach used. This may be owing to 2 reasons. First, the imaging sequence was optimized to cover a large area of the heart by visualizing 5 slices per heartbeat, which is more than in studies reported previously. This necessitated the use of a long EPI train to accelerate data acquisition, an approach that also induces artifacts. Second, a very small bolus of contrast agent was used to minimize the influence of the rest scan on the stress scan and to allow generating a valid LV input function without signal clipping owing to high contrast-agent concentrations.24 Such a small bolus, on the other hand, generates only mild visual differences and relatively low signal-to-noise ratios. Accordingly, the results from the visual assessment were disappointing. Better visual results can most probably be achieved by using higher doses of contrast agent and performing the stress study first. This approach, however, will most likely not allow semiquantification.
In future studies, sequences should be applied that either visualize 3 slices only with better spatial resolution or use other approaches (eg, faster gradients, parallel imaging) to allow to overcome the limitations encountered in the present study for visualizing the apical and basal slice.
Patient Population
Only patients with suspected CAD without previous angiography who were referred for a diagnostic coronary angiography were included into the study. Care was taken to also include patients with moderate pretest likelihood of CAD. The results of MR perfusion imaging had no impact on the decision whether or not to proceed to angiography, resulting in a relatively low prevalence of CAD (51%), which allows generalizing the results on an outpatient population. Possible problems of MR perfusion measurements may occur in patients with low ejection fraction or significant valvular disease, as these pathologies influence the compactness of the contrast agent bolus. In addition, patients with diabetes mellitus and arterial hypertension were excluded, as these patients have a high likelihood for perfusion defects, despite normal epicardial coronary arteries. The value of MR perfusion measurement in these patients remains to be evaluated in a different study and may show a lower accuracy.
For measurements of flow reserve, it is essential to induce maximal vasodilation. We made every effort to achieve this goal by using a potent vasodilator and excluding patients who did not adhere to the patient instructions and had taken medications or consumed substances reducing the effects of adenosine.
Limitations
Generating the SI time curves for calculation of the upslope from the MR images is time consuming. Even though care was taken to visualize the first pass of the contrast agent bolus during breath-holding, manual segmentation of the myocardium and correction for diaphragmatic motion had to be performed in 84% of the patients. Such a manual segmentation is tedious, allows user influence, and reduces the use of this technique for clinical routine measurements.
A drawback of the contrast agents used for MR perfusion measurements at the current time is the rapid diffusion into the extracellular space. This may also explain the smaller increase of perfusion reserve (factor, 1.5) in comparison to the literature, in which an increase of factor 4 to 5 was reported. In the future, intravascular contrast agents, which are currently under development, may be a step toward quantitative analysis.25 In addition, the relation between the perfusion reserve indices calculated in this study and the true alterations of flow needs to be determined.
Diagnostic accuracy may be further improved by a separate analysis of endocardial and epicardial segments because a reduction of endocardial perfusion is the most sensitive parameter for a reduction of blood flow.26 In a recent study, such an analysis of subendocardial data has been shown to allow the detection of patients with syndrome X.27 In the present study, the inner 10% and outer 30% of the myocardium were excluded from the analysis to avoid influence from the blood pool and to generate a stronger weighting of the subendocardium. However, spatial resolution did not allow for a differentiation into endocardium and epicardium.
The use of a retrospective analysis to calculate the ROC curves may lead to an optimistic estimate of the accuracy of the technique. However, ongoing studies in our institution do not show significant differences when prospectively applying the reported cutoff value.
Currently, a general limitation to MR perfusion imaging is the use of different technical approaches by different vendors and different centers, which inhibit comparison of results and limit multicenter trials.
Conclusions
MR can be used for the assessment of myocardial perfusion reserve and allows an accurate detection of significant CAD. It may be used to screen patients with suspected CAD and avoid cardiac catheterization in patients with negative MR. For an adequate accuracy, however, semiquantification is required. Before MR perfusion measurements can be routinely used in clinical practice, further improvement and automatization of quantification algorithms is required.
|
Acknowledgments |
|---|
This work is support by grants from Philips Medical Systems (Best, the Netherlands) and Schering (Berlin, Germany; both to Eike Nagel).
|
Footnotes |
|---|
Grant support was received from Philips Medical Systems and Schering, which supplied, respectively, the MRI tomography equipment and the gadolinium-DTPA used in this study. Dr Schnackenburg is also an employee of Philips Research Laboratories.
|
References |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
1. Go RT, Marwick TH, MacIntyre WJ, et al. A prospective comparison of rubidium 82 PET and thallium 201 SPECT myocardial perfusion imaging utilizing a single dipyridamole stress in the diagnosis of coronary artery disease. J Nucl Med. 1990; 31: 1899–1905.
2. Demer LL, Gould KL, Goldstein RA, et al. Assessment of coronary artery disease severity by positron emission tomography: comparison with quantitative arteriography in 193 patients. Circulation. 1989; 79: 825–835.
3. Muzik O, Duvernoy C, Beanlands RS, et al. Assessment of diagnostic performance of quantitative flow measurements in normal subjects and patients with angiographically documented coronary artery disease by means of nitrogen 13 ammonia and positron emission tomography. J Am Coll Cardiol. 1998; 31: 534–540.
4. Schwaiger M. Myocardial perfusion imaging with PET. J Nucl Med. 1994; 35: 693–698.
5. Klocke FJ, Simonetti OP, Judd RM, et al. Limits of detection of regional differences in vasodilated flow in viable myocardium by first-pass magnetic resonance perfusion imaging. Circulation. 2001; 104: 2412–2416.
6. Atkinson DJ, Burstein D, Edelman RR. First-pass cardiac perfusion: evaluation with ultrafast MR imaging. Radiology. 1990; 174: 757–762.
7. Manning WJ, Atkinson DJ, Grossman W, et al. First-pass nuclear magnetic resonance imaging studies using gadolinium-DTPA in patients with coronary artery disease. J Am Coll Cardiol. 1991; 18: 959–965.[Abstract]
8. Eichenberger AC, Schuiki E, Kochli VD, et al. Ischemic heart disease: assessment with gadolinium-enhanced ultrafast MR imaging and dipyridamole stress. J Magn Reson Imaging. 1994; 4: 425–431.[Medline] [Order article via Infotrieve]
9. Schaefer S, Lange RA, Gutekunst DP, et al. Contrast enhanced magnetic resonance imaging of hypoperfused myocardium. Invest Radiol. 1991; 26: 551–556.[CrossRef][Medline] [Order article via Infotrieve]
10. Cullen J, Horshfield M, Reek C, et al. A myocardial perfusion reserve index in humans using first-pass contrast enhanced magnetic resonance imaging. J Am Coll Cardiol. 1999; 33: 1386–1394.
11. Lauerma K, Virtanen KS, Sipila LM, et al. Multislice MRI in assessment of myocardial perfusion in patients with single vessel proximal left anterior descending coronary artery disease before and after revascularization. Circulation. 1997; 96: 2859–2867.
12. Schwitter J, Nanz D, Kneifel S, et al. Assessment of myocardial perfusion in coronary artery disease by magnetic resonance: a comparison with positron emission tomography and coronary angiography. Circulation. 2001; 103: 2230–2235.
13. Wilke N, Simm C, Zhang J, et al. Contrast-enhanced first pass myocardial perfusion imaging: correlation between myocardial blood flow in dogs at rest and during hyperemia. Magn Reson Med. 1993; 29: 485–497.[Medline] [Order article via Infotrieve]
14. Miller DD, Holmvang G, Gill JB, et al. MRI detection of myocardial perfusion changes by gadolinium DTPA infusion during dipyridamole hyperemia. Magn Reson Med. 1989; 10: 246–255.[Medline] [Order article via Infotrieve]
15. Larsson H, Fritz-Hansen T, Rostrup E, et al. Myocardial perfusion modeling using MRI. Magn Reson Med. 1996; 35: 716–726.[Medline] [Order article via Infotrieve]
16. Fritz-Hansen T, Rostrup E, Ring P, et al. Quantification of gadolinium-DPTA concentrations for different inversion times using an IR-turbo flash pulse sequence: a study on optimizing multislice perfusion imaging. Magn Reson Imaging. 1998; 16: 893–899.[CrossRef][Medline] [Order article via Infotrieve]
17. Vallee JP, Lazeyras F, Kasuboski L, et al. Quantification of myocardial perfusion with FAST sequence and Gd bolus in patients with normal cardiac function. J Magn Reson Imaging. 1999; 9: 197–203.[CrossRef][Medline] [Order article via Infotrieve]
18. Al-Saadi N, Nagel E, Gross M, et al. Noninvasive detection of myocardial ischemia from perfusion reserve based on cardiovascular magnetic resonance. Circulation. 2000; 101: 1379–1383.
19. Cerqueira MD, Weissman NJ, Dilsizian V, et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation. 2002; 105: 539–542.
20. Klein MA, Collier BD, Hellman RS, et al. Detection of chronic coronary artery disease: value of pharmacologically stressed, dynamically enhanced turbo fast low angle shot MR images. AJR Am J Roentgenol. 1993; 161: 257–263.
21. Sensky PR, Jivan A, Hudson NM, et al. Coronary artery disease: combined stress MR imaging protocol—1-stop evaluation of myocardial perfusion and function. Radiology. 2000; 215: 608–614.
22. Keijer JT, van Rossum AC, van Eenige MJ, et al. Magnetic resonance imaging of regional myocardial perfusion in patients with single-vessel coronary artery disease: quantitative comparison with 201thallium-SPECT and coronary angiography. J Magn Reson Imaging. 2000; 11: 607–615.[CrossRef][Medline] [Order article via Infotrieve]
23. Ibrahim T, Nekolla SG, Schreiber K, et al. Assessment of coronary flow reserve: comparison between contrast-enhanced magnetic resonance imaging and positron emission tomography. J Am Coll Cardiol. 2002; 39: 864–870.
24. Tweedle M, Wedeking P, Telser J, et al. Dependence of MR signal intensity on Gd tissue concentration over a broad dose range. Magn Reson Med. 1991; 22: 191–194.[Medline] [Order article via Infotrieve]
25. Kraitchman DL, Chin BB, Heldman AW, et al. MRI detection of myocardial perfusion defects due to coronary artery stenosis with MS-325. J Magn Reson Imaging. 2002; 15: 149–158.[CrossRef][Medline] [Order article via Infotrieve]
26. Bache RJ, Schwartz JS. Effect of perfusion pressure distal to a coronary stenosis on transmural myocardial blood flow. Circulation. 1982; 65: 928–935.
27. Panting J, Gatehouse P, Yang G, et al. Abnormal subendocardial perfusion in cardiac syndrome X detected by cardiovascular magnetic resonance imaging. N Engl J Med. 2002; 346: 1948–1953.
This article has been cited by other articles:
 |
|
 |
|
  P. Bernhardt, J. Spiess, B. Levenson, G. Pilz, B. Hofling, V. Hombach, and O. Strohm Combined Assessment of Myocardial Perfusion and Late Gadolinium Enhancement in Patients After Percutaneous Coronary Intervention or Bypass Grafts: A Multicenter Study of an Integrated Cardiovascular Magnetic Resonance Protocol J. Am. Coll. Cardiol. Img., November 1, 2009; 2(11): 1292 - 1300. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. D. Karamitsos, J. M. Francis, S. Myerson, J. B. Selvanayagam, and S. Neubauer The Role of Cardiovascular Magnetic Resonance Imaging in Heart Failure J. Am. Coll. Cardiol., October 6, 2009; 54(15): 1407 - 1424. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. D. Adler, A. Bystrup, K. C. Briley-Saebo, V. Mani, W. Young, S. Giovanonne, P. Altman, S. J. Kattman, J. A. Frank, H. J. Weinmann, et al. In Vivo Detection of Embryonic Stem Cell-Derived Cardiovascular Progenitor Cells Using Cy3-Labeled Gadofluorine M in Murine Myocardium J. Am. Coll. Cardiol. Img., September 1, 2009; 2(9): 1114 - 1122. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. C. Lee and N. P. Johnson Quantification of Absolute Myocardial Blood Flow by Magnetic Resonance Perfusion Imaging J. Am. Coll. Cardiol. Img., June 1, 2009; 2(6): 761 - 770. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Spuentrup, K. M. Ruhl, R. M. Botnar, A. J. Wiethoff, A. Buhl, V. Jacques, M. T. Greenfield, G. A. Krombach, R. W. Gunther, M. G. Vangel, et al. Molecular Magnetic Resonance Imaging of Myocardial Perfusion With EP-3600, a Collagen-Specific Contrast Agent: Initial Feasibility Study in a Swine Model Circulation, April 7, 2009; 119(13): 1768 - 1775. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Klein, E. Nagel, R. Gebker, S. Kelle, B. Schnackenburg, K. Graf, S. Dreysse, and E. Fleck Magnetic Resonance Adenosine Perfusion Imaging in Patients After Coronary Artery Bypass Graft Surgery J. Am. Coll. Cardiol. Img., April 1, 2009; 2(4): 437 - 445. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Lockie, E. Nagel, S. Redwood, and S. Plein Use of Cardiovascular Magnetic Resonance Imaging in Acute Coronary Syndromes Circulation, March 31, 2009; 119(12): 1671 - 1681. [Full Text] [PDF]
|
|
|
|
 |
|
 T. Kurita, H. Sakuma, K. Onishi, M. Ishida, K. Kitagawa, T. Yamanaka, T. Tanigawa, T. Kitamura, K. Takeda, and M. Ito Regional myocardial perfusion reserve determined using myocardial perfusion magnetic resonance imaging showed a direct correlation with coronary flow velocity reserve by Doppler flow wire Eur. Heart J., February 2, 2009; 30(4): 444 - 452. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Hoeks and D. Poldermans CHAPTER 34 Non-cardiac Surgery in Cardiac Patients ESC Textbook of Cardiovascular Medicine, January 1, 2009; 2(1): med-9780199566990-chapter - med-9780199566990-chapter. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W P Bandettini and A E Arai Advances in clinical applications of cardiovascular magnetic resonance imaging Heart, November 1, 2008; 94(11): 1485 - 1495. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Plein, S. Kozerke, D. Suerder, T. F. Luescher, J. P. Greenwood, P. Boesiger, and J. Schwitter High spatial resolution myocardial perfusion cardiac magnetic resonance for the detection of coronary artery disease Eur. Heart J., September 1, 2008; 29(17): 2148 - 2155. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Gebker, C. Jahnke, R. Manka, A. Hamdan, B. Schnackenburg, E. Fleck, and I. Paetsch Additional Value of Myocardial Perfusion Imaging During Dobutamine Stress Magnetic Resonance for the Assessment of Coronary Artery Disease Circ Cardiovasc Imaging, September 1, 2008; 1(2): 122 - 130. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Selvanayagam Women with chest pain expanding the diagnostic armamentarium. J. Am. Coll. Cardiol. Img., July 1, 2008; 1(4): 446 - 449. [Full Text] [PDF]
|
|
|
|
 |
|
 K. H. Schuleri, L. C. Amado, A. J. Boyle, M. Centola, A. P. Saliaris, M. R. Gutman, K. E. Hatzistergos, B. N. Oskouei, J. M. Zimmet, R. G. Young, et al. Early improvement in cardiac tissue perfusion due to mesenchymal stem cells Am J Physiol Heart Circ Physiol, May 1, 2008; 294(5): H2002 - H2011. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Gebker, C. Jahnke, I. Paetsch, S. Kelle, B. Schnackenburg, E. Fleck, and E. Nagel Diagnostic Performance of Myocardial Perfusion MR at 3 T in Patients with Coronary Artery Disease Radiology, April 1, 2008; 247(1): 57 - 63. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Gebker, C. Jahnke, I. Paetsch, B. Schnackenburg, S. Kozerke, A. Bornstedt, E. Fleck, and E. Nagel MR Myocardial Perfusion Imaging with k-Space and Time Broad-Use Linear Acquisition Speed-up Technique: Feasibility Study Radiology, December 1, 2007; 245(3): 863 - 871. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M Fenchel, A Franow, P Martirosian, M Engels, U Kramer, N I Stauder, U Helber, H Vogler, C D Claussen, and S Miller 1 M Gd-chelate (gadobutrol) for multislice first-pass magnetic resonance myocardial perfusion imaging Br. J. Radiol., November 1, 2007; 80(959): 884 - 892. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Merkle, J. Wohrle, O. Grebe, T. Nusser, M. Kunze, H. A Kestler, M. Kochs, and V. Hombach Assessment of myocardial perfusion for detection of coronary artery stenoses by steady-state, free-precession magnetic resonance first-pass imaging Heart, November 1, 2007; 93(11): 1381 - 1385. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. R. Nandalur, B. A. Dwamena, A. F. Choudhri, M. R. Nandalur, and R. C. Carlos Diagnostic Performance of Stress Cardiac Magnetic Resonance Imaging in the Detection of Coronary Artery Disease: A Meta-Analysis J. Am. Coll. Cardiol., October 2, 2007; 50(14): 1343 - 1353. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. B. Selvanayagam, A. S.H. Cheng, M. Jerosch-Herold, K. Rahimi, I. Porto, W. van Gaal, K. M. Channon, S. Neubauer, and A. P. Banning Effect of Distal Embolization on Myocardial Perfusion Reserve After Percutaneous Coronary Intervention: A Quantitative Magnetic Resonance Perfusion Study Circulation, September 25, 2007; 116(13): 1458 - 1464. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Costa, S. Shoemaker, H. Futamatsu, C. Klassen, D. J. Angiolillo, M. Nguyen, A. Siuciak, P. Gilmore, M. M. Zenni, L. Guzman, et al. Quantitative Magnetic Resonance Perfusion Imaging Detects Anatomic and Physiologic Coronary Artery Disease as Measured by Coronary Angiography and Fractional Flow Reserve J. Am. Coll. Cardiol., August 7, 2007; 50(6): 514 - 522. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. A.C. Vermeltfoort, O. Bondarenko, P. G.H.M. Raijmakers, D. A.M. Odekerken, A. F.M. Kuijper, A. Zwijnenburg, M. J.E. van der Vis-Melsen, J. W.R. Twisk, A. M. Beek, G. J.J. Teule, et al. Is subendocardial ischaemia present in patients with chest pain and normal coronary angiograms? A cardiovascular MR study Eur. Heart J., July 1, 2007; 28(13): 1554 - 1558. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. S.H. Cheng, T. J. Pegg, T. D. Karamitsos, N. Searle, M. Jerosch-Herold, R. P. Choudhury, A. P. Banning, S. Neubauer, M. D. Robson, and J. B. Selvanayagam Cardiovascular Magnetic Resonance Perfusion Imaging at 3-Tesla for the Detection of Coronary Artery Disease: A Comparison With 1.5-Tesla J. Am. Coll. Cardiol., June 26, 2007; 49(25): 2440 - 2449. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. A. Barmeyer, A. Stork, K. Muellerleile, C. Tiburtius, A. K. Schofer, T. A. Heitzer, T. Hofmann, G. Adam, T. Meinertz, and G. K. Lund Contrast-enhanced Cardiac MR Imaging in the Detection of Reduced Coronary Flow Velocity Reserve Radiology, May 1, 2007; 243(2): 377 - 385. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. B. Marcu, A. M. Beek, and A. C. van Rossum Clinical applications of cardiovascular magnetic resonance imaging. Can. Med. Assoc. J., October 10, 2006; 175(8): 911 - 917. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Kahan and Y. Allanore Primary myocardial involvement in systemic sclerosis Rheumatology, October 1, 2006; 45(suppl_4): iv14 - iv17. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. D. Rosen, J. A.C. Lima, K. Nasir, T. Edvardsen, A. R. Folsom, S. Lai, D. A. Bluemke, and M. Jerosch-Herold Lower Myocardial Perfusion Reserve Is Associated With Decreased Regional Left Ventricular Function in Asymptomatic Participants of the Multi-Ethnic Study of Atherosclerosis Circulation, July 25, 2006; 114(4): 289 - 297. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. C. Cury, C. A. M. Cattani, L. A. G. Gabure, D. J. Racy, J. M. de Gois, U. Siebert, S. S. Lima, and T. J. Brady Diagnostic Performance of Stress Perfusion and Delayed-Enhancement MR Imaging in Patients with Coronary Artery Disease. Radiology, July 1, 2006; 240(1): 39 - 45. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V Positano, A Pingitore, B Scattini, M F Santarelli, D De Marchi, B Favilli, M Lombardi, and L Landini Myocardial perfusion by first pass contrast magnetic resonance: a robust method for quantitative regional assessment of perfusion reserve index. Heart, May 1, 2006; 92(5): 689 - 690. [Full Text] [PDF]
|
|
|
|
|
|
C. M. Kramer When Two Tests Are Better Than One: Adding Late Gadolinium Enhancement to First-Pass Perfusion Cardiovascular Magnetic Resonance J. Am. Coll. Cardiol., April 18, 2006; 47(8): 1639 - 1640. [Full Text] [PDF]
|
|
|
|
|
|
I. Klem, J. F. Heitner, D. J. Shah, M. H. Sketch Jr, V. Behar, J. Weinsaft, P. Cawley, M. Parker, M. Elliott, R. M. Judd, et al. Improved Detection of Coronary Artery Disease by Stress Perfusion Cardiovascular Magnetic Resonance With the Use of Delayed Enhancement Infarction Imaging J. Am. Coll. Cardiol., April 18, 2006; 47(8): 1630 - 1638. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Fenchel, A. M. Scheule, N. I. Stauder, U. Kramer, K. Tomaschko, T. Nagele, C. Bretschneider, H.-P. Schlemmer, C. D. Claussen, and S. Miller Atherosclerotic Disease: Whole-Body Cardiovascular Imaging with MR System with 32 Receiver Channels and Total-Body Surface Coil Technology--Initial Clinical Results Radiology, December 1, 2005; 238(1): 280 - 291. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. B. Selvanayagam, M. Jerosch-Herold, I. Porto, D. Sheridan, A. S.H. Cheng, S. E. Petersen, N. Searle, K. M. Channon, A. P. Banning, and S. Neubauer Resting Myocardial Blood Flow Is Impaired in Hibernating Myocardium: A Magnetic Resonance Study of Quantitative Perfusion Assessment Circulation, November 22, 2005; 112(21): 3289 - 3296. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Ishida, H. Sakuma, N. Kato, N. Ishida, K. Kitagawa, T. Shimono, I. Yada, and K. Takeda Contrast-enhanced MR Imaging for Evaluation of Coronary Artery Disease before Elective Repair of Aortic Aneurysm Radiology, November 1, 2005; 237(2): 458 - 464. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Paetsch, C. Jahnke, E. Fleck, and E. Nagel Current clinical applications of stress wall motion analysis with cardiac magnetic resonance imaging Eur J Echocardiogr, October 1, 2005; 6(5): 317 - 326. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Fenchel, A. Franow, N. I. Stauder, U. Kramer, U. Helber, C. D. Claussen, and S. Miller Myocardial Perfusion after Angioplasty in Patients Suspected of Having Single-Vessel Coronary Artery Disease: Improvement Detected at Rest-Stress First-Pass Perfusion MR Imaging--Initial Experience Radiology, October 1, 2005; 237(1): 67 - 74. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Fenchel, U. Helber, U. Kramer, N. I. Stauder, A. Franow, C. D. Claussen, and S. Miller Detection of Regional Myocardial Perfusion Deficit Using Rest and Stress Perfusion MRI: A Feasibility Study Am. J. Roentgenol., September 1, 2005; 185(3): 627 - 635. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O Vignaux, Y Allanore, C Meune, O Pascal, D Duboc, S Weber, P Legmann, and A Kahan Evaluation of the effect of nifedipine upon myocardial perfusion and contractility using cardiac magnetic resonance imaging and tissue Doppler echocardiography in systemic sclerosis Ann Rheum Dis, September 1, 2005; 64(9): 1268 - 1273. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Fuster and R. J. Kim Frontiers in Cardiovascular Magnetic Resonance Circulation, July 5, 2005; 112(1): 135 - 144. [Full Text] [PDF]
|
|
|
|
|
|
H. Sakuma, N. Suzawa, Y. Ichikawa, K. Makino, T. Hirano, K. Kitagawa, and K. Takeda Diagnostic Accuracy of Stress First-Pass Contrast-Enhanced Myocardial Perfusion MRI Compared with Stress Myocardial Perfusion Scintigraphy Am. J. Roentgenol., July 1, 2005; 185(1): 95 - 102. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Bodi, J. Sanchis, A. Losada, M. P. Lopez-Lereu, D. Garcia, M. Pellicer, F. J. Chorro, and A. Llacer Usefulness of quantitative intravenous myocardial contrast echocardiography to analyze microvasculature perfusion in patients with a recent myocardial infarction and an open infarct-related artery: comparison with intracoronary myocardial contrast echocardiography Eur J Echocardiogr, June 1, 2005; 6(3): 164 - 174. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Plein, A. Radjenovic, J. P. Ridgway, D. Barmby, J. P. Greenwood, S. G. Ball, and M. U. Sivananthan Coronary Artery Disease: Myocardial Perfusion MR Imaging with Sensitivity Encoding versus Conventional Angiography Radiology, May 1, 2005; 235(2): 423 - 430. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. G. Elkington, P. D. Gatehouse, T. M. Cannell, J. C. Moon, S. K. Prasad, D. N. Firmin, and D. J. Pennell Comparison of Hybrid Echo-planar Imaging and FLASH Myocardial Perfusion Cardiovascular MR Imaging Radiology, April 1, 2005; 235(1): 237 - 243. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. H. Mieres, L. J. Shaw, A. Arai, M. J. Budoff, S. D. Flamm, W. G. Hundley, T. H. Marwick, L. Mosca, A. R. Patel, M. A. Quinones, et al. Role of Noninvasive Testing in the Clinical Evaluation of Women With Suspected Coronary Artery Disease: Consensus Statement From the Cardiac Imaging Committee, Council on Clinical Cardiology, and the Cardiovascular Imaging and Intervention Committee, Council on Cardiovascular Radiology and Intervention, American Heart Association Circulation, February 8, 2005; 111(5): 682 - 696. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. K Prasad, R. G Assomull, and D. J Pennell Recent developments in non-invasive cardiology BMJ, December 11, 2004; 329(7479): 1386 - 1389. [Full Text] [PDF]
|
|
|
|
|
|
I. Paetsch, C. Jahnke, A. Wahl, R. Gebker, M. Neuss, E. Fleck, and E. Nagel Comparison of Dobutamine Stress Magnetic Resonance, Adenosine Stress Magnetic Resonance, and Adenosine Stress Magnetic Resonance Perfusion Circulation, August 17, 2004; 110(7): 835 - 842. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S.D. Wolff, J. Schwitter, R. Coulden, M.G. Friedrich, D.A. Bluemke, R.W. Biederman, E.T. Martin, A.J. Lansky, F. Kashanian, T.K.F. Foo, et al. Myocardial First-Pass Perfusion Magnetic Resonance Imaging: A Multicenter Dose-Ranging Study Circulation, August 10, 2004; 110(6): 732 - 737. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. C. Lee, O. P. Simonetti, K. R. Harris, T. A. Holly, R. M. Judd, E. Wu, and F. J. Klocke Magnetic Resonance Versus Radionuclide Pharmacological Stress Perfusion Imaging for Flow-Limiting Stenoses of Varying Severity Circulation, July 6, 2004; 110(1): 58 - 65. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. D Flamm High-dose dobutamine stress cardiac magnetic resonance imaging - has its time come? Eur. Heart J., July 2, 2004; 25(14): 1183 - 1184. [Full Text] [PDF]
|
|
|
|
 |
|
 M. Galinanes, M. Loubani, P. R. Sensky, A. Hassouna, G. R. Cherryman, J. N. Leverment, and N. J. Samani Efficacy of transmyocardial laser revascularization and thoracic sympathectomy for the treatment of refractory angina Ann. Thorac. Surg., July 1, 2004; 78(1): 122 - 128. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Shan, G. Constantine, M. Sivananthan, and S. D. Flamm Role of Cardiac Magnetic Resonance Imaging in the Assessment of Myocardial Viability Circulation, March 23, 2004; 109(11): 1328 - 1334. [Full Text] [PDF]
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||